{"id":"https://openalex.org/W2601774271","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.6038","title":"The results of first-line chemotherapy in 108 patients affected by recurrent or metastatic salivary gland malignacies (RMSGM).","display_name":"The results of first-line chemotherapy in 108 patients affected by recurrent or metastatic salivary gland malignacies (RMSGM).","alternate_titles":[],"publication_year":2013,"publication_date":"2013-05-20","ids":{"openalex":"https://openalex.org/W2601774271","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.6038","mag":"2601774271"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.15_suppl.6038","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.6038","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.6038","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2601774271"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057001950","display_name":"Mario Airoldi","orcid":"https://orcid.org/0000-0002-1202-9973","observed_orcids":["https://orcid.org/0000-0002-1202-9973"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mario Airoldi","raw_affiliation_strings":["2nd Medical Oncology Division, A. O. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2nd Medical Oncology Division, A. O. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020056645","display_name":"Massimiliano Garzaro","orcid":"https://orcid.org/0000-0001-9949-1177","observed_orcids":["https://orcid.org/0000-0001-9949-1177"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Massimiliano Garzaro","raw_affiliation_strings":["1st ENT Division, Surgical Sciences Department, University of Turin, Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st ENT Division, Surgical Sciences Department, University of Turin, Turin, Italy","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084106174","display_name":"Luca Raimondo","orcid":"https://orcid.org/0000-0003-0660-6655","observed_orcids":["https://orcid.org/0000-0003-0660-6655"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Luca Raimondo","raw_affiliation_strings":["1st ENT Division, Surgical Sciences Department, University of Turin, Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st ENT Division, Surgical Sciences Department, University of Turin, Turin, Italy","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029036674","display_name":"Fulvia Pedani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Fulvia Pedani","raw_affiliation_strings":["2nd Medical Oncology Division, A. O. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2nd Medical Oncology Division, A. O. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102820341","display_name":"Elisa Bellini","orcid":"https://orcid.org/0000-0001-8618-9446","observed_orcids":["https://orcid.org/0000-0001-8618-9446"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elisa Bellini","raw_affiliation_strings":["2nd Medical Oncology Division, A. O. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2nd Medical Oncology Division, A. O. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087068181","display_name":"Oliviero Ostellino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Oliviero Ostellino","raw_affiliation_strings":["2nd Medical Oncology Division, A. O. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2nd Medical Oncology Division, A. O. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103085544","display_name":"Giuseppe Riva","orcid":"https://orcid.org/0000-0002-1825-7635","observed_orcids":["https://orcid.org/0000-0002-1825-7635"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Riva","raw_affiliation_strings":["1st ENT Division, Surgical Sciences Department, University of Turin, Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st ENT Division, Surgical Sciences Department, University of Turin, Turin, Italy","institution_ids":["https://openalex.org/I55143463"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089972709","display_name":"Giancarlo Pecorari","orcid":"https://orcid.org/0000-0002-6884-4563","observed_orcids":["https://orcid.org/0000-0002-6884-4563"]},"institutions":[{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giancarlo Pecorari","raw_affiliation_strings":["1st ENT Division, Surgical Sciences Department, University of Turin, Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st ENT Division, Surgical Sciences Department, University of Turin, Turin, Italy","institution_ids":["https://openalex.org/I55143463"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"15_suppl","first_page":"6038","last_page":"6038"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11035","display_name":"Salivary Gland Tumors Diagnosis and Treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11035","display_name":"Salivary Gland Tumors Diagnosis and Treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11521","display_name":"Salivary Gland Disorders and Functions","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.9369999766349792},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9380000233650208},{"id":"https://openalex.org/keywords/vinorelbine","display_name":"vinorelbine","score":0.9909999966621399},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.8510000109672546},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.7639999985694885},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9919999837875366},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.640999972820282},{"id":"https://openalex.org/keywords/palliative-chemotherapy","display_name":"palliative chemotherapy","score":0.6800000071525574},{"id":"https://openalex.org/keywords/adenoid-cystic-carcinoma","display_name":"adenoid cystic carcinoma","score":0.8450000286102295},{"id":"https://openalex.org/keywords/undifferentiated-carcinoma","display_name":"undifferentiated carcinoma","score":0.6930000185966492},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.6050000190734863},{"id":"https://openalex.org/keywords/survival-outcomes","display_name":"survival outcomes","score":0.40400001406669617},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.5789999961853027},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5899999737739563},{"id":"https://openalex.org/keywords/karnofsky-performance-status","display_name":"Karnofsky performance status","score":0.6269999742507935}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9467379450798035},{"id":"https://openalex.org/C2779231225","wikidata":"https://www.wikidata.org/wiki/Q356005","display_name":"Adenoid cystic carcinoma","level":3,"score":0.6444460153579712},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5775125622749329},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.5734593868255615},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5580953359603882},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.5460886359214783},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4911350905895233},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.441329687833786},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.3651922345161438},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.351955771446228},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.33738625049591064},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.08089256286621094}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.15_suppl.6038","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.6038","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.6038","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2964151366","https://openalex.org/W2325489602","https://openalex.org/W2317551761","https://openalex.org/W2464767007","https://openalex.org/W2306233388","https://openalex.org/W3000297338","https://openalex.org/W2596657019","https://openalex.org/W4415942348","https://openalex.org/W1596423757","https://openalex.org/W2070165953"],"abstract_inverted_index":{"6038":[0],"Background:":[1],"Recurrent/metastatic":[2],"salivary":[3],"gland":[4],"malignancies":[5],"(RMSGM)":[6],"are":[7],"not":[8],"manageable":[9],"by":[10],"means":[11],"of":[12,33,38,49,139,282,301],"surgery":[13],"and/or":[14],"radiotherapy;":[15],"chemotherapy":[16],"(CT)":[17],"represents":[18],"a":[19,244],"palliative":[20],"strategy":[21],"without":[22],"any":[23],"curative":[24],"purposes.":[25],"In":[26],"this":[27],"abstract":[28],"we":[29],"report":[30],"the":[31,201,227,229,299],"results":[32,242],"CT":[34,140,253,260,283],"in":[35,205,213,220,310],"108":[36,43],"cases":[37],"RMSGM.":[39,50,311],"Methods:":[40],"We":[41],"enrolled":[42],"patients":[44],"with":[45,243,261],"radiologically":[46],"documented":[47],"progression":[48],"Five":[51],"pts":[52,63,72,85,104,121,164,182,192,199,207,215,222],"received":[53],"cisplatin":[54],"(DDP)":[55],"100":[56],"mg/sm":[57,67,76,94,98,107,112,131],"d":[58],"1,":[59],"q":[60,69,81,100,116,133],"3wks;":[61,70],"8":[62],"doxorubicin":[64],"(DOX)":[65],"75":[66],"d1,":[68],"30":[71,75,214],"vinorelbine":[73],"(VNB)":[74],"d.":[77,113],"1":[78],"and":[79,119,153,169,194,217,247],"8,":[80],"3":[82,101,117,134],"wks;":[83,102],"9":[84],"DDP":[86,105,225,278],"60":[87,93],"mg/":[88],"sm":[89],"+":[90,95,109,126,210],"epirubicin":[91],"(EPI)":[92],"5-FU":[96],"600":[97],"d.1,":[99,132],"42":[103,163],"80":[106],"d.1":[108],"VNB":[110,239],"25":[111],"1,8":[114],",":[115],"wks,":[118],"14":[120],"carboplatin":[122],"(CBDCA)":[123],"AUC":[124],"5.5":[125],"paclitaxel":[127],"(Taxol;":[128],"TAX)":[129],"175":[130],"wks.":[135],"The":[136,280],"maximum":[137],"number":[138],"cycles":[141],"was":[142,177,203],"6.":[143],"Results:":[144],"Patients":[145],"characteristics":[146],"were":[147],"as":[148,178,266,268],"follows:":[149],"65":[150],"males":[151],"(60%)":[152],"43":[154],"females":[155],"(40%);":[156],"median":[157],"age:":[158],"57":[159],"yrs":[160],"(range":[161],"20-74);":[162],"(39%)":[165],"had":[166],"ECOG":[167],"PS=0":[168],"66":[170],"pts(61%)":[171],"PS":[172],"1-2":[173],"(0-2);":[174],"histological":[175],"evaluation":[176],"follow:":[179],"adenocarcinoma":[180],"28":[181],"(26%),":[183],"adenoid":[184],"cystic":[185],"carcinoma":[186,190],"63pts":[187],"(58%),":[188],"undifferentiated":[189],"12":[191],"(11%)":[193],"malignant":[195],"mixed":[196],"tumors":[197],"5":[198],"(5%);":[200],"disease":[202],"local":[204,209],"40":[206],"(37%),":[208],"distant":[211],"metastases":[212],"(28%)":[216],"only":[218],"metastatic":[219],"38":[221],"(35%).":[223],"Conclusions:":[224],"is":[226,265,286],"probably":[228],"most":[230],"effective":[231,256,267],"single":[232],"drug":[233,252,259],"scheme;":[234],"our":[235,296],"data":[236,297],"suggest":[237],"that":[238],"has":[240],"superimposeable":[241],"better":[245],"gastroenteric":[246],"renal":[248],"toxicity":[249],"profile.":[250],"Single":[251],"seems":[254,271],"less":[255],"than":[257,277],"multi":[258],"DDP-based":[262],"schemes.":[263],"DDP+EPI+5-FU":[264],"DDP+VNB;":[269],"CBDCA+TAX":[270],"to":[272,306],"have":[273],"worse":[274],"clinical":[275,308],"outcomes":[276,309],"combinations.":[279],"impact":[281],"on":[284,290],"symptoms":[285],"quite":[287],"good":[288],"while":[289],"survival":[291],"needs":[292],"further":[293],"investigations,":[294],"moreover":[295],"confirm":[298],"need":[300],"new":[302],"biological":[303],"target":[304],"agents":[305],"improve":[307],"[Table:":[312],"see":[313],"text]":[314]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2601774271","counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-04-07T00:00:00"}
